Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT06714266 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06714266
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-15
- Primary completion
- 2026-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.